 |
市场调查报告书
商品编码
1550539
疫苗市场：按类型、技术、适应症、给药途径及地区分类Vaccines Market, By Type, By Technology, By Disease Indication, By Route of Administration, By Geography |
||||||
预计2024年全球疫苗市场规模为771.2亿美元，预计2031年将达1,161亿美元，2024年至2031年复合年增长率为6%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 771.2亿美元 |
| 实际资料 | 2019年至2023年 | 预测期 | 从2024年到2031年 |
| 预测 2024-2031 年复合年增长率： | 6.00% | 2031年价值预测 | 1161亿美元 |
近年来，由于各种感染疾病的蔓延和疫苗製造技术的进步，全球疫苗市场经历了稳定成长。疫苗有助于增强对某些疾病的免疫力，使高风险族群免受危险感染疾病的危及生命的影响。免疫意识的提高，特别是在开发中国家，正在推动全球对先进且负担得起的疫苗的需求。此外，主要製造商推出组合疫苗有助于提高疫苗接种率并减轻医疗资源的压力。政府和国际组织对免疫计划的持续支持预计将在预测期内推动全球疫苗市场的成长。
市场动态：
全球疫苗市场主要由感染疾病率上升、疫苗製造技术进步以及政府对免疫计划的日益关注所推动。据世界卫生组织 (WHO) 称，疫苗接种每年可预防 2 至 300 万人死亡。针对某些疾病的强制性疫苗接种以及全球消除疾病的努力也推动了市场的成长。然而，新疫苗研发伴随的研发成本飙升、监管部门的严格核准以及因错误讯息而犹豫不决等因素，是阻碍疫苗广泛使用的因素。同时，无需冷藏即可承受高温的热稳定疫苗、可针对突变病毒提供保护的细胞疫苗技术以及提高低收入和中等收入国家疫苗接种率的倡议的开发将在未来继续增长。丰厚的机会。
本研究的主要特点
本报告对全球疫苗市场进行了详细分析，并呈现了以2022年为基准年的预测期（2024-2031）的市场规模和年均增长率。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
该报告根据公司亮点、产品系列、主要业绩、财务表现和策略等参数，提供了全球疫苗市场主要企业的概况。
本研究涵盖的主要企业包括辉瑞、默克、赛诺菲巴斯德、葛兰素史克 (GSK)、阿斯特捷利康、强生、CSL Limited 和印度血清研究所。
本报告中的见解将帮助负责人和公司经营团队就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球疫苗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
透过分析全球疫苗市场时所使用的各种策略矩阵，将有助于相关人员做出决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
第四章全球疫苗市场，依类型，2024-2031
- 单价疫苗
- 多效价疫苗
第五章 全球疫苗市场（依技术），2024-2031 年
- 结合疫苗
- 重组疫苗
- 灭活次单位疫苗
- 减毒活疫苗
- 类毒素疫苗
- 其他疫苗技术
第六章全球疫苗市场，按剂型，2024-2031
- 锭剂/胶囊
- 液体
- 奶油
- 凝胶
- 其他的
第 7 章 全球疫苗市场（依适应症），2024-2031 年
- 肺炎链球菌感染
- 流感
- 联合疫苗
- HPV
- 病菌感染感染
- 带状疱疹
- 轮状病毒
- MMR
- 水痘
- 肝炎
- DTP
- 脊髓灰质炎
- RSV
- 其他疾病的征兆
第八章 全球疫苗市场，依给药途径，2024-2031 年
- 肌肉注射
- 皮下的
- 口服
- 鼻内
第九章全球疫苗市场，按地区，2019-2031
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中部非洲
第10章竞争格局
- GlaxoSmithKline plc（GSK）
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Moderna, Inc.
- AstraZeneca
- Johnson & Johnson
- Novavax, Inc.
- CSL Limited
- Emergent BioSolutions Inc.
- Bharat Biotech
- Serum Institute of India
- BioNTech SE
- Takeda Pharmaceutical Company
- Sinovac Biotech Ltd.
- Sinopharm（China National Pharmaceutical Group）
- Vaxart, Inc.
- Inovio Pharmaceuticals, Inc.
- Valneva SE
- Vaccitech plc
第十一章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十二章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
The Global Vaccines Market is estimated to be valued at USD 77.12 Billion in 2024 and is expected to reach USD 116.10 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 77.12 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 6.00% | 2031 Value Projection: | US$ 116.10 Bn |
The global vaccines market has been witnessing steady growth over the past few years due to the rising prevalence of various infectious diseases and technological advancements in vaccine production. Vaccines aid in building immunity against specific diseases and allow populations at risk to be protected from the life-threatening effects of dangerous infections. Growing awareness about immunization, especially in developing nations is propelling the demand for advanced and affordable vaccines globally. Furthermore, the introduction of combination vaccines by major manufacturers is encouraging higher vaccination rates and reducing the burden on healthcare resources. Continued support from governments and international organizations towards immunization programs is expected to drive the global vaccines market growth during the forecast period.
Market Dynamics:
The global vaccines market is primarily driven by the rising incidence of infectious diseases, technological advancements in vaccine production, and growing focus on immunization programs by governments. According to the World Health Organization (WHO), immunization averts an estimated 2-3 million deaths annually. Mandates on vaccination of certain diseases and worldwide efforts towards disease eradication also provide momentum to market growth. However, high R&D costs associated with new vaccine development, stringent regulatory approvals, and vaccine hesitancy due to misinformation are some of the factors hindering the widespread adoption of vaccines. On the other hand, development of thermostable vaccines that can withstand high temperatures without refrigeration, cell-based vaccine technologies offering protection against mutating viruses, and initiatives to drive vaccine uptake in low and middle-income countries are expected to unlock lucrative opportunities for players in the coming years.
Key features of the study:
This report provides in-depth analysis of the global vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer, Merck, Sanofi Pasteur, GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, CSL Limited, and Serum Institute of India
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaccines market.
Detailed Segmentation-
- By Type Insights (Revenue, USD Bn, 2019 - 2031)
- Monovalent Vaccines
- Mulitvalent Vaccines
- By Technology Insights (Revenue, USD Bn, 2019 - 2031)
- Conjugate Vaccines
- Recombinant Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Other Vaccine Technologies
- By Dosage Form Insights (Revenue, USD Bn, 2019 - 2031)
- Tablets/Capsules
- Liquids
- Creams
- Gels
- Others
- By Disease Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Pneumococcal Disease
- Influenza
- Combination Vaccines
- HPV
- Meningococcal Disease
- Herpes Zoster
- Rotavirus
- MMR
- Varicella
- Hepatitis
- DTP
- Polio
- RSV
- Other Disease Indications
- By Route Of Administration: Insights (Revenue, USD Bn, 2019 - 2031)
- Intramuscular
- Subcutaneous
- Oral
- Intranasal
- By Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- GlaxoSmithKline plc (GSK)
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Moderna, Inc.
- AstraZeneca
- Johnson & Johnson
- Novavax, Inc.
- CSL Limited
- Emergent BioSolutions Inc.
- Bharat Biotech
- Serum Institute of India
- BioNTech SE
- Takeda Pharmaceutical Company
- Sinovac Biotech Ltd.
- Sinopharm (China National Pharmaceutical Group)
- Vaxart, Inc.
- Inovio Pharmaceuticals, Inc.
- Valneva SE
- Vaccitech plc
Table of Contents
1. RESEARCH OBJECTIVES AND ASSUMPTIONS
- Research Objectives
- Assumptions
- Abbreviations
2. MARKET PURVIEW
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Vaccines Market, By Type
- Global Vaccines Market, By Technology
- Global Vaccines Market, By Dosage Form
- Global Vaccines Market, By Disease Indication
- Global Vaccines Market, By Route of Administration
- Global Vaccines Market, By Region
3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Vaccines Market, By Type, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Monovalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Multivalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Vaccines Market, By Technology, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Inactivated and Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other Vaccine Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Vaccines Market, By Dosage Form, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Tablets/Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Liquids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Vaccines Market, By Disease Indication, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Pneumococcal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Combination Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- HPV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Meningococcal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Herpes Zoster
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Rotavirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- MMR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Varicella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- DTP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Polio
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- RSV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other Disease Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Vaccines Market, By Route of Administration, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Vaccines Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. COMPETITIVE LANDSCAPE
- GlaxoSmithKline plc (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Moderna, Inc.
- AstraZeneca
- Johnson & Johnson
- Novavax, Inc.
- CSL Limited
- Emergent BioSolutions Inc.
- Bharat Biotech
- Serum Institute of India
- BioNTech SE
- Takeda Pharmaceutical Company
- Sinovac Biotech Ltd.
- Sinopharm (China National Pharmaceutical Group)
- Vaxart, Inc.
- Inovio Pharmaceuticals, Inc.
- Valneva SE
- Vaccitech plc
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
传染病疫苗联合研究与授权协议：2016-2024
成人疫苗市场：按疫苗类型、适应症和最终用户划分 - 全球预测 2025-2030
减毒活病毒疫苗市场报告：2030 年趋势、预测与竞争分析
多效价疫苗市场报告：2030 年趋势、预测与竞争分析
类毒素疫苗市场报告：2030 年趋势、预测与竞争分析
鱼疫苗市场 - 全球产业规模、份额、趋势、机会和预测，按疫苗类型、管理途径、地区和竞争细分，2019-2029F
2030 年疫苗市场预测：按疫苗类型、疾病类型、给药途径、年龄层、最终用户和地区进行全球分析
成人疫苗市场：按疫苗、按疫苗类型、按技术、按地区
疫苗市场规模、份额、趋势分析报告：按类型、途径、适应疾病、年龄层、分销管道、地区、细分市场预测，2024-2030
全球呼吸道病毒疫苗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测